EuroPCR 2025 Hot Line & Late-Breaking Trial Collection

  • Published:  08 May 2025
  • Views: 

    Views Icon

    520

  • Likes: 

    Heart Icon

    0

Up Next

EuroPCR 2025 Hot Line & Late-Breaking Trial Collection

  • Published:  08 May 2025
  • Views: 

    Views Icon

    520

  • Likes: 

    Heart Icon

    0

Average (ratings)
No ratings
Your rating
About the episode

Step into the forefront of interventional cardiology with distinguished experts Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) as they provide a comprehensive overview of EuroPCR 2025's most anticipated late-breaking trials.

Optimize your conference preparation through this essential preview, where expert commentary outlines the clinical significance of this innovative research and its potential to reshape therapeutic approaches and patient management strategies.

Trials covered include:
UK TAVI
COMPARE TAVI
ACURATE IDE
PROTECTED TAVR and BHF PROTECT TAVI Meta Analyses
FAITAVI
Coronary Function Testing Vs Standard Care in ANOCA
CAREER
ICARE-OFDI
RETRIEVE-AMI
COMPARE-ABSORB
BIOADAPTOR RCT
FLAVOR
PERFECT PSP
bRIGHT
TRINITY
VISTA
Trisol TTVR System
EXPLORE
AMEND TS Pilot Study

Overview

Dive into our collection covering the hot line and late-breaking trials presented at EuroPCR 2025. Reviewing the sessions you don't want to miss, interventional experts Prof Nicolas Van Mieghem and Dr Joost Daemen will be leading our regular series View From the Thoraxcenter. For a deeper dive into the most anticipated trials, our Expert Interviews have you covered.

More from this programme

Part 1

View From the Thoraxcenter

Part 2

Expert Interviews

1 session
Watch now

Faculty Biographies

Nicolas M Van Mieghem

Nicolas M Van Mieghem

Medical Director

Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.

Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors. 

His current research focuses on cerebral embolic protection during TAVI and the search for improved…

View full profile

Comments

You must be to comment. If you are not registered, you can register here.